产品详情
| 中文名称:注射用头孢曲松钠 | 英文名称:Ceftriaxone Sodium for injection |
| 品牌: 安徽丰原 | 产地: 安徽 |
| 产品类别: 抗生素 |
2026-04-22
注射用头孢曲松钠
Ceftriaxone Sodium for injection
1支/RMB;10支/RMB
安徽丰原
安徽
抗生素
注射用头孢曲松钠为工伤医保甲类双跨的第三代头孢菌素类抗生素，主要成分为头孢曲松钠，呈白色或类白色结晶性粉末。该药适用于敏感菌引起的下呼吸道感染、尿路胆道感染、腹腔盆腔感染及手术期预防，并可单剂治疗单纯性淋病。
Ceftriaxone sodium for injection is a third-generation cephalosporin antibiotic classified as a dual-category Class A drug for work-related injuries and medical insurance coverage. Its active ingredient is ceftriaxone sodium, appearing as a white or off-white crystalline powder. This medication is indicated for lower respiratory tract infections, urinary tract infections, biliary tract infections, intra-abdominal and pelvic infections caused by susceptible bacteria, as well as perioperative prophylaxis. It can also be used as a single-dose treatment for uncomplicated gonorrhea.
This product is a white or off white crystalline powder; Odorless.
Used for the prevention of lower respiratory tract infections, urinary tract infections, biliary tract infections caused by sensitive pathogenic bacteria, as well as abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, sepsis, meningitis, and surgical infections. This product can treat simple gonorrhea with a single dose.
Calculate 1.0g based on C18H18N8O7S3
包装：一支/盒，一针一水/盒（1g+10ml），10支/盒
关键字： 注射用头孢曲松钠;Ceftriaxone Sodium f;antibiotics;
公司简介
AnHui BBCA Pharmaceutical Co., Ltd.?is found in 1960s?and?was listed in Sep 4, 2000 in Shenzhen stock Exchange after obtaining the approval of China Securities Regulatory Commission. Up to the end of 2008, the company had more than 4500 employees and a total capital of about 18.25 billion RMB.?BBCA Pharmaceuticals is constituted of three systems which are pharmaceutical R&D, production, and sale. It has 5 pharmaceutical plants and 45 GMP certified production line, mainly involving R&D, production and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine,and possessing nine classes of products including antipyretic-analgesic drug, cardiovascular drug, antibiotic, nervous system drug,anti-tumor drug, antiulcer drug, hormones drug, nutriceutical,and preparation of traditional Chinese medicine,etc.?Depending on BBCA advanced technology and abundant strength, BBCA Pharm exports products to all over the world, including Europe, North America, Africa, Southeast Asia and Central Asia.?
| 成立日期 |
2008-12-04
（18年）
|
注册资本 |
5000万人民币
|
| 员工人数 |
1-10人 |
年营业额 |
￥ 100万以内 |
| 主营行业 |
原料药,维生素类,氨基酸及其衍生物,解热镇痛药,其他抗感染类 |
经营模式 |
贸易,工厂 |